346 related articles for article (PubMed ID: 27312105)
1. Single-dose treatment with a humanized neutralizing antibody affords full protection of a human transgenic mouse model from lethal Middle East respiratory syndrome (MERS)-coronavirus infection.
Qiu H; Sun S; Xiao H; Feng J; Guo Y; Tai W; Wang Y; Du L; Zhao G; Zhou Y
Antiviral Res; 2016 Aug; 132():141-8. PubMed ID: 27312105
[TBL] [Abstract][Full Text] [Related]
2. Recombinant Receptor-Binding Domains of Multiple Middle East Respiratory Syndrome Coronaviruses (MERS-CoVs) Induce Cross-Neutralizing Antibodies against Divergent Human and Camel MERS-CoVs and Antibody Escape Mutants.
Tai W; Wang Y; Fett CA; Zhao G; Li F; Perlman S; Jiang S; Zhou Y; Du L
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795425
[TBL] [Abstract][Full Text] [Related]
3. A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV.
Zhao G; He L; Sun S; Qiu H; Tai W; Chen J; Li J; Chen Y; Guo Y; Wang Y; Shang J; Ji K; Fan R; Du E; Jiang S; Li F; Du L; Zhou Y
J Virol; 2018 Sep; 92(18):. PubMed ID: 29950421
[TBL] [Abstract][Full Text] [Related]
4. A recombinant receptor-binding domain of MERS-CoV in trimeric form protects human dipeptidyl peptidase 4 (hDPP4) transgenic mice from MERS-CoV infection.
Tai W; Zhao G; Sun S; Guo Y; Wang Y; Tao X; Tseng CK; Li F; Jiang S; Du L; Zhou Y
Virology; 2016 Dec; 499():375-382. PubMed ID: 27750111
[TBL] [Abstract][Full Text] [Related]
5. A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein.
Li Y; Wan Y; Liu P; Zhao J; Lu G; Qi J; Wang Q; Lu X; Wu Y; Liu W; Zhang B; Yuen KY; Perlman S; Gao GF; Yan J
Cell Res; 2015 Nov; 25(11):1237-49. PubMed ID: 26391698
[TBL] [Abstract][Full Text] [Related]
6. Importance of Neutralizing Monoclonal Antibodies Targeting Multiple Antigenic Sites on the Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein To Avoid Neutralization Escape.
Wang L; Shi W; Chappell JD; Joyce MG; Zhang Y; Kanekiyo M; Becker MM; van Doremalen N; Fischer R; Wang N; Corbett KS; Choe M; Mason RD; Van Galen JG; Zhou T; Saunders KO; Tatti KM; Haynes LM; Kwong PD; Modjarrad K; Kong WP; McLellan JS; Denison MR; Munster VJ; Mascola JR; Graham BS
J Virol; 2018 May; 92(10):. PubMed ID: 29514901
[TBL] [Abstract][Full Text] [Related]
7. Acute Respiratory Infection in Human Dipeptidyl Peptidase 4-Transgenic Mice Infected with Middle East Respiratory Syndrome Coronavirus.
Iwata-Yoshikawa N; Okamura T; Shimizu Y; Kotani O; Sato H; Sekimukai H; Fukushi S; Suzuki T; Sato Y; Takeda M; Tashiro M; Hasegawa H; Nagata N
J Virol; 2019 Mar; 93(6):. PubMed ID: 30626685
[TBL] [Abstract][Full Text] [Related]
8. A Human DPP4-Knockin Mouse's Susceptibility to Infection by Authentic and Pseudotyped MERS-CoV.
Fan C; Wu X; Liu Q; Li Q; Liu S; Lu J; Yang Y; Cao Y; Huang W; Liang C; Ying T; Jiang S; Wang Y
Viruses; 2018 Aug; 10(9):. PubMed ID: 30142928
[TBL] [Abstract][Full Text] [Related]
9. Receptor-binding domain of MERS-CoV with optimal immunogen dosage and immunization interval protects human transgenic mice from MERS-CoV infection.
Wang Y; Tai W; Yang J; Zhao G; Sun S; Tseng CK; Jiang S; Zhou Y; Du L; Gao J
Hum Vaccin Immunother; 2017 Jul; 13(7):1615-1624. PubMed ID: 28277821
[TBL] [Abstract][Full Text] [Related]
10. Human Neutralizing Monoclonal Antibody Inhibition of Middle East Respiratory Syndrome Coronavirus Replication in the Common Marmoset.
Chen Z; Bao L; Chen C; Zou T; Xue Y; Li F; Lv Q; Gu S; Gao X; Cui S; Wang J; Qin C; Jin Q
J Infect Dis; 2017 Jun; 215(12):1807-1815. PubMed ID: 28472421
[TBL] [Abstract][Full Text] [Related]
11. Elevated Human Dipeptidyl Peptidase 4 Expression Reduces the Susceptibility of hDPP4 Transgenic Mice to Middle East Respiratory Syndrome Coronavirus Infection and Disease.
Algaissi A; Agrawal AS; Han S; Peng BH; Luo C; Li F; Chan TS; Couch RB; Tseng CK
J Infect Dis; 2019 Feb; 219(5):829-835. PubMed ID: 30256968
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus.
Corti D; Zhao J; Pedotti M; Simonelli L; Agnihothram S; Fett C; Fernandez-Rodriguez B; Foglierini M; Agatic G; Vanzetta F; Gopal R; Langrish CJ; Barrett NA; Sallusto F; Baric RS; Varani L; Zambon M; Perlman S; Lanzavecchia A
Proc Natl Acad Sci U S A; 2015 Aug; 112(33):10473-8. PubMed ID: 26216974
[TBL] [Abstract][Full Text] [Related]
13. Characterization and Demonstration of the Value of a Lethal Mouse Model of Middle East Respiratory Syndrome Coronavirus Infection and Disease.
Tao X; Garron T; Agrawal AS; Algaissi A; Peng BH; Wakamiya M; Chan TS; Lu L; Du L; Jiang S; Couch RB; Tseng CT
J Virol; 2016 Jan; 90(1):57-67. PubMed ID: 26446606
[TBL] [Abstract][Full Text] [Related]
14. Development of human neutralizing monoclonal antibodies for prevention and therapy of MERS-CoV infections.
Ying T; Li H; Lu L; Dimitrov DS; Jiang S
Microbes Infect; 2015 Feb; 17(2):142-8. PubMed ID: 25456101
[TBL] [Abstract][Full Text] [Related]
15. CD8+ T Cells and Macrophages Regulate Pathogenesis in a Mouse Model of Middle East Respiratory Syndrome.
Coleman CM; Sisk JM; Halasz G; Zhong J; Beck SE; Matthews KL; Venkataraman T; Rajagopalan S; Kyratsous CA; Frieman MB
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795435
[TBL] [Abstract][Full Text] [Related]
16. Neutralizing Monoclonal Antibodies as Promising Therapeutics against Middle East Respiratory Syndrome Coronavirus Infection.
Han HJ; Liu JW; Yu H; Yu XJ
Viruses; 2018 Nov; 10(12):. PubMed ID: 30513619
[TBL] [Abstract][Full Text] [Related]
17. Ultrapotent Human Neutralizing Antibody Repertoires Against Middle East Respiratory Syndrome Coronavirus From a Recovered Patient.
Niu P; Zhang S; Zhou P; Huang B; Deng Y; Qin K; Wang P; Wang W; Wang X; Zhou J; Zhang L; Tan W
J Infect Dis; 2018 Sep; 218(8):1249-1260. PubMed ID: 29846635
[TBL] [Abstract][Full Text] [Related]
18. Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Infection, Immunological Response, and Vaccine Development.
Mubarak A; Alturaiki W; Hemida MG
J Immunol Res; 2019; 2019():6491738. PubMed ID: 31089478
[TBL] [Abstract][Full Text] [Related]
19. Towards a solution to MERS: protective human monoclonal antibodies targeting different domains and functions of the MERS-coronavirus spike glycoprotein.
Widjaja I; Wang C; van Haperen R; Gutiérrez-Álvarez J; van Dieren B; Okba NMA; Raj VS; Li W; Fernandez-Delgado R; Grosveld F; van Kuppeveld FJM; Haagmans BL; Enjuanes L; Drabek D; Bosch BJ
Emerg Microbes Infect; 2019; 8(1):516-530. PubMed ID: 30938227
[TBL] [Abstract][Full Text] [Related]
20. A Highly Immunogenic, Protective, and Safe Adenovirus-Based Vaccine Expressing Middle East Respiratory Syndrome Coronavirus S1-CD40L Fusion Protein in a Transgenic Human Dipeptidyl Peptidase 4 Mouse Model.
Hashem AM; Algaissi A; Agrawal AS; Al-Amri SS; Alhabbab RY; Sohrab SS; S Almasoud A; Alharbi NK; Peng BH; Russell M; Li X; Tseng CK
J Infect Dis; 2019 Oct; 220(10):1558-1567. PubMed ID: 30911758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]